| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP13A4 ERCC6 ABCA13 SMC4 KIF9 ATP1A4 DDX24 HSPA2 SNRNP200 HSP90AA4P | 5.65e-05 | 441 | 97 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | enzyme regulator activity | DOCK1 ARHGAP42 STARD13 FLT3 ERCC6 DUSP19 ADGRV1 CDC37 PPP2R1B PPP3R1 PPP3R2 GUCA1B CCNA1 C4A C4B RPL5 ALK PLXNB1 | 1.46e-04 | 1418 | 97 | 18 | GO:0030234 |
| GeneOntologyMolecularFunction | calcium-dependent protein serine/threonine phosphatase regulator activity | 2.31e-04 | 5 | 97 | 2 | GO:0008597 | |
| GeneOntologyMolecularFunction | calcium ion binding | VSNL1 PCDHGA11 ADGRV1 PCDH17 DUOX1 CDH22 CDH20 PPP3R1 PPP3R2 GUCA1B AIF1 TNNC1 | 2.73e-04 | 749 | 97 | 12 | GO:0005509 |
| Domain | - | 5.16e-05 | 261 | 94 | 8 | 1.10.238.10 | |
| Domain | EF-hand_7 | 6.92e-05 | 85 | 94 | 5 | PF13499 | |
| Domain | EF_HAND_1 | 7.67e-05 | 204 | 94 | 7 | PS00018 | |
| Domain | EF-hand-dom_pair | 1.00e-04 | 287 | 94 | 8 | IPR011992 | |
| Domain | EFh | 1.47e-04 | 158 | 94 | 6 | SM00054 | |
| Domain | Tox-GHH_dom | 1.49e-04 | 4 | 94 | 2 | IPR028916 | |
| Domain | Tox-GHH | 1.49e-04 | 4 | 94 | 2 | PF15636 | |
| Domain | Ten_N | 1.49e-04 | 4 | 94 | 2 | IPR009471 | |
| Domain | Ten_N | 1.49e-04 | 4 | 94 | 2 | PF06484 | |
| Domain | TENEURIN_N | 1.49e-04 | 4 | 94 | 2 | PS51361 | |
| Domain | EF_HAND_2 | 1.66e-04 | 231 | 94 | 7 | PS50222 | |
| Domain | EF_hand_dom | 1.71e-04 | 232 | 94 | 7 | IPR002048 | |
| Domain | Parvalbumin | 2.48e-04 | 5 | 94 | 2 | IPR008080 | |
| Domain | Anaphylatoxin_comp_syst | 2.48e-04 | 5 | 94 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 2.48e-04 | 5 | 94 | 2 | IPR001840 | |
| Domain | YD | 2.48e-04 | 5 | 94 | 2 | IPR006530 | |
| Domain | EF_Hand_1_Ca_BS | 2.56e-04 | 175 | 94 | 6 | IPR018247 | |
| Domain | ANATO | 5.18e-04 | 7 | 94 | 2 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 5.18e-04 | 7 | 94 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 5.18e-04 | 7 | 94 | 2 | PS01177 | |
| Domain | SLC12A_fam | 5.18e-04 | 7 | 94 | 2 | IPR004842 | |
| Domain | ANATO | 5.18e-04 | 7 | 94 | 2 | PF01821 | |
| Domain | NAD_binding_6 | 5.18e-04 | 7 | 94 | 2 | PF08030 | |
| Domain | FAD_binding_8 | 5.18e-04 | 7 | 94 | 2 | PF08022 | |
| Domain | FAD-bd_8 | 5.18e-04 | 7 | 94 | 2 | IPR013112 | |
| Domain | Fe_red_NAD-bd_6 | 5.18e-04 | 7 | 94 | 2 | IPR013121 | |
| Domain | Anaphylatoxin/fibulin | 5.18e-04 | 7 | 94 | 2 | IPR000020 | |
| Domain | SLC12_C | 6.88e-04 | 8 | 94 | 2 | IPR018491 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 6.88e-04 | 8 | 94 | 2 | IPR019565 | |
| Domain | Thiol-ester_cl | 6.88e-04 | 8 | 94 | 2 | PF10569 | |
| Domain | MacrogloblnA2_CS | 6.88e-04 | 8 | 94 | 2 | IPR019742 | |
| Domain | SLC12 | 6.88e-04 | 8 | 94 | 2 | PF03522 | |
| Domain | EF-hand_1 | 1.03e-03 | 152 | 94 | 5 | PF00036 | |
| Domain | A2M | 1.10e-03 | 10 | 94 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.10e-03 | 10 | 94 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.10e-03 | 10 | 94 | 2 | IPR011626 | |
| Domain | A2M_recep | 1.10e-03 | 10 | 94 | 2 | PF07677 | |
| Domain | A2M_comp | 1.10e-03 | 10 | 94 | 2 | PF07678 | |
| Domain | A2M_N | 1.10e-03 | 10 | 94 | 2 | PF01835 | |
| Domain | A2M_N | 1.10e-03 | 10 | 94 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.10e-03 | 10 | 94 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.10e-03 | 10 | 94 | 2 | PS00477 | |
| Domain | E3_UB_ligase_RBR | 1.10e-03 | 10 | 94 | 2 | IPR031127 | |
| Domain | A2M_N_2 | 1.10e-03 | 10 | 94 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 1.10e-03 | 10 | 94 | 2 | IPR001599 | |
| Domain | Ferric_reduct | 1.60e-03 | 12 | 94 | 2 | PF01794 | |
| Domain | Fe3_Rdtase_TM_dom | 1.60e-03 | 12 | 94 | 2 | IPR013130 | |
| Domain | ARM-type_fold | 1.62e-03 | 339 | 94 | 7 | IPR016024 | |
| Domain | NHL | 1.89e-03 | 13 | 94 | 2 | PS51125 | |
| Domain | IBR | 2.19e-03 | 14 | 94 | 2 | PF01485 | |
| Domain | IBR | 2.19e-03 | 14 | 94 | 2 | SM00647 | |
| Domain | Cadherin_CS | 2.24e-03 | 109 | 94 | 4 | IPR020894 | |
| Domain | IBR_dom | 2.52e-03 | 15 | 94 | 2 | IPR002867 | |
| Domain | CADHERIN_1 | 2.55e-03 | 113 | 94 | 4 | PS00232 | |
| Domain | Cadherin | 2.55e-03 | 113 | 94 | 4 | PF00028 | |
| Domain | CADHERIN_2 | 2.63e-03 | 114 | 94 | 4 | PS50268 | |
| Domain | - | 2.63e-03 | 114 | 94 | 4 | 2.60.40.60 | |
| Domain | CA | 2.72e-03 | 115 | 94 | 4 | SM00112 | |
| Domain | Cadherin-like | 2.80e-03 | 116 | 94 | 4 | IPR015919 | |
| Domain | Cadherin | 2.98e-03 | 118 | 94 | 4 | IPR002126 | |
| Domain | C345C | 3.24e-03 | 17 | 94 | 2 | SM00643 | |
| Domain | Cation_ATPase_N | 3.64e-03 | 18 | 94 | 2 | PF00690 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 3.64e-03 | 18 | 94 | 2 | IPR008930 | |
| Domain | Cation_ATPase_N | 3.64e-03 | 18 | 94 | 2 | SM00831 | |
| Domain | NTR | 4.05e-03 | 19 | 94 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 4.05e-03 | 19 | 94 | 2 | IPR018933 | |
| Domain | Fd_Rdtase_FAD-bd | 4.05e-03 | 19 | 94 | 2 | IPR017927 | |
| Domain | FAD_FR | 4.05e-03 | 19 | 94 | 2 | PS51384 | |
| Domain | ATPase_P-typ_cation-transptr_N | 4.05e-03 | 19 | 94 | 2 | IPR004014 | |
| Domain | Riboflavin_synthase-like_b-brl | 4.05e-03 | 19 | 94 | 2 | IPR017938 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | GPI SMC4 HUWE1 SND1 FHOD1 HTATSF1 C4A C4B HADHA HSPA2 SNRNP200 RPL5 HDLBP | 9.63e-10 | 477 | 98 | 13 | 31300519 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | STARD13 GPI ERCC6 SPTLC2 SMC4 HEATR1 HUWE1 CDC37 LIG3 SND1 FHOD1 KDM2A HADHA DDX24 G6PD SNRNP200 RPL5 HDLBP | 4.00e-08 | 1353 | 98 | 18 | 29467282 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GPI HEATR1 NR3C1 GPKOW STAT3 CDC37 LIG3 SND1 FHOD1 HTATSF1 G6PD SNRNP200 RPL5 AFF4 HDLBP | 5.60e-08 | 934 | 98 | 15 | 33916271 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | STARD13 GPI HUWE1 CDC37 DUOX1 SLC12A2 SND1 HADHA PEAK1 HSPA2 G6PD SNRNP200 RPL5 HDLBP | 6.32e-08 | 807 | 98 | 14 | 30575818 |
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 34480088 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | GPI SMC4 HUWE1 NR3C1 CDC37 PHKA2 LIG3 SND1 DNAAF10 HADHA PATJ HSPA2 G6PD SNRNP200 RPL5 HDLBP | 1.35e-07 | 1149 | 98 | 16 | 35446349 |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | PPFIBP1 HUWE1 CDC37 PHKA2 PPP2R1B PPP3R1 UQCRB HADHA DDX24 HSPA2 SNRNP200 RPL5 | 2.58e-07 | 639 | 98 | 12 | 23443559 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | GPI SPTLC2 SMC4 HUWE1 NR3C1 GPKOW CDC37 PPP2R1B SND1 HTATSF1 UQCRB HADHA ARIH1 DDX24 G6PD RPL5 HDLBP | 2.60e-07 | 1367 | 98 | 17 | 32687490 |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | GPI DUSP19 PTP4A1 CDC37 LIG3 PPP2R1B DNAAF10 HADHA PEAK1 SNRNP200 RPL5 | 6.78e-07 | 573 | 98 | 11 | 28330616 |
| Pubmed | 2.30e-06 | 210 | 98 | 7 | 16565220 | ||
| Pubmed | GPI GABARAPL2 ITPKB NWD2 TENM4 SND1 SORCS2 DLG3 C4A C4B HADHA PEAK1 HSPA2 SNRNP200 RPL5 HDLBP | 2.44e-06 | 1431 | 98 | 16 | 37142655 | |
| Pubmed | 2.57e-06 | 10 | 98 | 3 | 19167759 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | PPFIBP1 SMC4 GABARAPL2 HEATR1 PTP4A1 CDC37 LIG3 SND1 CCNA1 HTATSF1 DLG3 HADHA DDX24 SNRNP200 HDLBP | 3.07e-06 | 1284 | 98 | 15 | 17353931 |
| Pubmed | SMC4 HEATR1 HUWE1 STAT3 SND1 KDM2A PEAK1 PATJ SNRNP200 HDLBP | 3.58e-06 | 549 | 98 | 10 | 38280479 | |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 4.31e-06 | 231 | 98 | 7 | 36597993 | |
| Pubmed | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. | 4.40e-06 | 85 | 98 | 5 | 16051665 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | SMC4 HEATR1 HUWE1 CDC37 SND1 HTATSF1 HADHA ARIH1 DDX24 SNRNP200 RPL5 | 4.91e-06 | 704 | 98 | 11 | 29955894 |
| Pubmed | DOCK1 PPFIBP1 SMC4 STAT3 SND1 HADHA PEAK1 PATJ SNRNP200 RPL5 HDLBP | 5.18e-06 | 708 | 98 | 11 | 39231216 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SMC4 HEATR1 HUWE1 NR3C1 CASZ1 STAT3 PHKA2 LIG3 EPC1 KDM2A DDX24 SNRNP200 | 5.42e-06 | 857 | 98 | 12 | 25609649 |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 7.86e-06 | 2 | 98 | 2 | 16565498 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 15998580 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 19062096 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 7.86e-06 | 2 | 98 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 7.86e-06 | 2 | 98 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 7.86e-06 | 2 | 98 | 2 | 17645767 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 12737943 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 12207352 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 7.86e-06 | 2 | 98 | 2 | 27758680 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 32816914 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 22387014 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 7.86e-06 | 2 | 98 | 2 | 23749435 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 23918728 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 7.86e-06 | 2 | 98 | 2 | 3037333 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 22633955 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 11726230 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 7.86e-06 | 2 | 98 | 2 | 6950384 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 7.86e-06 | 2 | 98 | 2 | 8428773 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 7.86e-06 | 2 | 98 | 2 | 21345967 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 2572548 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 2302180 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 7.86e-06 | 2 | 98 | 2 | 18091514 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 29080553 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 7.86e-06 | 2 | 98 | 2 | 25339671 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 17728371 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 6149580 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 6149581 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 12115608 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 3542363 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 2387317 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 24386318 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 23975180 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 16908004 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 7365238 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 7391573 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 17971360 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 7.86e-06 | 2 | 98 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 7.86e-06 | 2 | 98 | 2 | 17971229 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 6881182 | ||
| Pubmed | [Leptin promotes the expression of hTERT via STAT3 in breast cancer cells]. | 7.86e-06 | 2 | 98 | 2 | 23158658 | |
| Pubmed | PlexinB1 Promotes Nuclear Translocation of the Glucocorticoid Receptor. | 7.86e-06 | 2 | 98 | 2 | 31861264 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 19272180 | ||
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 7.86e-06 | 2 | 98 | 2 | 17921792 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 7.86e-06 | 2 | 98 | 2 | 6978711 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 35898513 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 28873507 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 276882 | ||
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 7.86e-06 | 2 | 98 | 2 | 6832377 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 3794341 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 22785613 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 32691186 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 21430068 | ||
| Pubmed | STAT3 acts as a co-activator of glucocorticoid receptor signaling. | 7.86e-06 | 2 | 98 | 2 | 9388192 | |
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 7.86e-06 | 2 | 98 | 2 | 8390682 | |
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 7.86e-06 | 2 | 98 | 2 | 3902619 | |
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 7.86e-06 | 2 | 98 | 2 | 7373044 | |
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 7.86e-06 | 2 | 98 | 2 | 3696167 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 7.86e-06 | 2 | 98 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 7.86e-06 | 2 | 98 | 2 | 16098595 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 24551274 | ||
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 7.86e-06 | 2 | 98 | 2 | 15787745 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 30026462 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 6559257 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 7.86e-06 | 2 | 98 | 2 | 34299197 | |
| Pubmed | Protein kinase C-θ promotes Th17 differentiation via upregulation of Stat3. | 7.86e-06 | 2 | 98 | 2 | 22586032 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 7.86e-06 | 2 | 98 | 2 | 20506482 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 12480675 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 26800705 | ||
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 7.86e-06 | 2 | 98 | 2 | 15390104 | |
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 7.86e-06 | 2 | 98 | 2 | 1699796 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 7.86e-06 | 2 | 98 | 2 | 2997024 | |
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 7.86e-06 | 2 | 98 | 2 | 3624865 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 21857912 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 29471502 | ||
| Interaction | PINK1 interactions | GPI SMC4 HUWE1 STAT3 CDC37 SND1 FHOD1 HTATSF1 C4A C4B HADHA HSPA2 SNRNP200 RPL5 HSP90AA4P HDLBP | 1.25e-07 | 679 | 96 | 16 | int:PINK1 |
| Interaction | HSP90AA1 interactions | STARD13 FLT3 SMC4 GABARAPL2 HUWE1 NR3C1 TERT STAT3 CDC37 SND1 SPHKAP C4A PRKCQ HADHA DDX24 HSPA2 SNRNP200 RPL5 ALK HSP90AA4P | 1.67e-06 | 1263 | 96 | 20 | int:HSP90AA1 |
| Interaction | PRICKLE1 interactions | 9.80e-06 | 60 | 96 | 5 | int:PRICKLE1 | |
| Interaction | ATP13A4 interactions | 2.25e-05 | 2 | 96 | 2 | int:ATP13A4 | |
| Interaction | PARP1 interactions | ERCC6 SMC4 HEATR1 HUWE1 NR3C1 GPKOW CASZ1 CDC37 LIG3 SND1 FHOD1 TENM1 KDM2A HADHA HSPA2 RPL5 AFF4 HDLBP | 4.33e-05 | 1316 | 96 | 18 | int:PARP1 |
| Interaction | ALK interactions | 4.60e-05 | 271 | 96 | 8 | int:ALK | |
| Interaction | TMEM200A interactions | 4.71e-05 | 42 | 96 | 4 | int:TMEM200A | |
| Interaction | NAA40 interactions | GPI HEATR1 NR3C1 GPKOW STAT3 CDC37 LIG3 SND1 FHOD1 HTATSF1 G6PD SNRNP200 RPL5 AFF4 HDLBP | 5.75e-05 | 978 | 96 | 15 | int:NAA40 |
| Interaction | SRC interactions | DOCK1 FLT3 NR3C1 TERT STAT3 CDC37 GUCA1B CCNA1 HADHA HSPA2 ALK HDLBP | 7.38e-05 | 664 | 96 | 12 | int:SRC |
| Interaction | MET interactions | 7.40e-05 | 290 | 96 | 8 | int:MET | |
| GeneFamily | Protein phosphatase 3 regulatory subunits|EF-hand domain containing | 1.48e-05 | 2 | 70 | 2 | 697 | |
| GeneFamily | EF-hand domain containing | 2.18e-05 | 219 | 70 | 7 | 863 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 5.23e-04 | 9 | 70 | 2 | 1234 | |
| GeneFamily | CD molecules|Type II classical cadherins | 1.12e-03 | 13 | 70 | 2 | 1186 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | DOCK1 ARHGAP42 STARD13 PPFIBP1 PABPC4L NR3C1 STAT3 ITPKB SLC12A2 HAAO PEAK1 SLC12A7 HSPA2 | 8.34e-06 | 795 | 98 | 13 | M39050 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | PPFIBP1 HEATR1 STAT3 ITPKB PTP4A1 EPC1 ARIH1 PATJ DDX24 AFF4 | 1.15e-05 | 474 | 98 | 10 | M40991 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | DOCK1 ARHGAP42 RNF19A ABCA13 HUWE1 RUFY2 LIG3 PPP3R1 TNNC1 HDLBP | 8.41e-06 | 379 | 96 | 10 | gudmap_developingKidney_e15.5_1000_k3 |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.80e-09 | 175 | 97 | 8 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.80e-09 | 175 | 97 | 8 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.28e-07 | 178 | 97 | 7 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-07 | 184 | 97 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-07 | 184 | 97 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-07 | 184 | 97 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.55e-07 | 197 | 97 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.25e-06 | 157 | 97 | 6 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.43e-06 | 187 | 97 | 6 | 4d2115a05ec36dd179ca1d4a525f2d4501aea557 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 3.43e-06 | 187 | 97 | 6 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.54e-06 | 188 | 97 | 6 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.54e-06 | 188 | 97 | 6 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.24e-06 | 194 | 97 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.63e-06 | 197 | 97 | 6 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.77e-06 | 198 | 97 | 6 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.05e-06 | 200 | 97 | 6 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 5.05e-06 | 200 | 97 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-unknown_epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.71e-06 | 130 | 97 | 5 | 1491e8975520e99c527a5b5bee64875d124f7bf4 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.59e-05 | 144 | 97 | 5 | 6f1158c85e1d50ef6f2c67abdb2dc855a9786b9a | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh|GI_large-bowel / Manually curated celltypes from each tissue | 2.89e-05 | 163 | 97 | 5 | 4104d3b9748b39cb0744c9be76db21bdda566a0d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Eya1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.12e-05 | 82 | 97 | 4 | 42017b8ace6f142a8358213c95a2632226c3a867 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 3.53e-05 | 170 | 97 | 5 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.53e-05 | 170 | 97 | 5 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 176 | 97 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 4.17e-05 | 176 | 97 | 5 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.28e-05 | 177 | 97 | 5 | f10f77130dbb2c0ad1b436ceb4fb1deac2b0267c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.52e-05 | 179 | 97 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 4.52e-05 | 179 | 97 | 5 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.52e-05 | 179 | 97 | 5 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-05 | 181 | 97 | 5 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.76e-05 | 181 | 97 | 5 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-05 | 182 | 97 | 5 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.89e-05 | 182 | 97 | 5 | d4cb23b5a974c096a0ce84b47fe351eef44894d7 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.02e-05 | 183 | 97 | 5 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.15e-05 | 184 | 97 | 5 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.15e-05 | 184 | 97 | 5 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.28e-05 | 185 | 97 | 5 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.28e-05 | 185 | 97 | 5 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.42e-05 | 186 | 97 | 5 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.42e-05 | 186 | 97 | 5 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.56e-05 | 187 | 97 | 5 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.56e-05 | 187 | 97 | 5 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.56e-05 | 187 | 97 | 5 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.56e-05 | 187 | 97 | 5 | 5d3d68519c8e19f10c29f9d81712125be78ca15a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.56e-05 | 187 | 97 | 5 | 5c73010fe4c85fb5cc1273f5504821229ca0cc4b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.56e-05 | 187 | 97 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.56e-05 | 187 | 97 | 5 | 93c78fc7f126132eb84feb47be2c4e8c568b9e91 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 187 | 97 | 5 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 187 | 97 | 5 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.70e-05 | 188 | 97 | 5 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-05 | 188 | 97 | 5 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 5.85e-05 | 189 | 97 | 5 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.85e-05 | 189 | 97 | 5 | 784ace2be87f2ecb19490f4974f63a559516e0eb | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.99e-05 | 190 | 97 | 5 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.99e-05 | 190 | 97 | 5 | 5c64b727669b23d2a23c8ad1d5d6caab7af37d56 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.99e-05 | 190 | 97 | 5 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.99e-05 | 190 | 97 | 5 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.99e-05 | 190 | 97 | 5 | 07f21386ea6eb23416a537d2250e3042efe93fb0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.99e-05 | 190 | 97 | 5 | b56c55f608b30f7379941ac7d5f0f5200f305fca | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.99e-05 | 190 | 97 | 5 | ae97df1b06bcd46c05759b53c35dc8fea97f4ac1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.99e-05 | 190 | 97 | 5 | 1c3d601422efa60fad8565f9ccd9032b847e4a91 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.15e-05 | 191 | 97 | 5 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.15e-05 | 191 | 97 | 5 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.15e-05 | 191 | 97 | 5 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-05 | 191 | 97 | 5 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.15e-05 | 191 | 97 | 5 | 2b056cbe2e82e056e1f798974999378460eb1d16 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.15e-05 | 191 | 97 | 5 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.15e-05 | 191 | 97 | 5 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.30e-05 | 192 | 97 | 5 | f7e4509003d71f805b9d4587098e90d2897b6739 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 6.30e-05 | 192 | 97 | 5 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.30e-05 | 192 | 97 | 5 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.30e-05 | 192 | 97 | 5 | 705ce805cb00a53793b57bcf466d0fbec590a83c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.46e-05 | 193 | 97 | 5 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.46e-05 | 193 | 97 | 5 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.46e-05 | 193 | 97 | 5 | 4e78ddc96d8e403a21c4a303b1f26512d2ac91e8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.46e-05 | 193 | 97 | 5 | dd9874898587fe9fd9cf2aebc2e0579dcf06944e | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 194 | 97 | 5 | f08a7618a9ccf12e4a7620235ae662a8abc521af | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 195 | 97 | 5 | f41a68b7c2621594db8d8952e301eeadc96be26f | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 7.11e-05 | 197 | 97 | 5 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-05 | 198 | 97 | 5 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.28e-05 | 198 | 97 | 5 | 0b9d3518d60d877e1423517fab374381bf678a2b | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.28e-05 | 198 | 97 | 5 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-05 | 198 | 97 | 5 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.46e-05 | 199 | 97 | 5 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.64e-05 | 200 | 97 | 5 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | Macroglial|World / cells hierarchy compared to all cells using T-Statistic | 7.64e-05 | 200 | 97 | 5 | e6935ad49216d2500c15c05cbc2b89402c65e838 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 7.64e-05 | 200 | 97 | 5 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.64e-05 | 200 | 97 | 5 | 6a44439e4a7ce3627271375b04cfcfb9467218f4 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.64e-05 | 200 | 97 | 5 | 8d51b4f7b7002ee51401ebe5eaca1e8f04bfadd5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A--L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.64e-05 | 200 | 97 | 5 | cb1f4b0d66da5b0466ff17b29e7034d451d93e4f | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.33e-04 | 119 | 97 | 4 | e868453c02dcf0e07821886b81ca739887d43c67 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crh_4930553C11Rik_|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.82e-04 | 129 | 97 | 4 | 6bc85761dea1f97c19bb379a99e4daf85d53201e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.23e-04 | 136 | 97 | 4 | e3a2425ba5ef538dbacab1479e682837ae42a888 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 138 | 97 | 4 | 19ffd66256fa94d728138d37d0a5a3bac7722dbb | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 138 | 97 | 4 | 321070b6900887b27da0f2b25808a05a8ab89ee7 | |
| ToppCell | moderate-Epithelial-unknown_epithelial|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.35e-04 | 138 | 97 | 4 | afefa8233c67aa744e939156bc538449bf6bd05b | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.42e-04 | 139 | 97 | 4 | 9e9f29f92dbe65b26cc78b3a1c00778c6a701f5b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-04 | 142 | 97 | 4 | 5b6b0c611c83b23ef7289854a515b78f6cf84500 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.70e-04 | 143 | 97 | 4 | 24fd24846fbef049af669a57d42fcc18928d2b27 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-04 | 145 | 97 | 4 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| Drug | endothall thioanhydride | 1.49e-07 | 12 | 97 | 4 | CID000176108 | |
| Drug | 2,2,2-trifluoroethyl phosphate | 2.59e-06 | 7 | 97 | 3 | CID000151044 | |
| Drug | 1-benzothiophene-2-carboxamide | 2.59e-06 | 7 | 97 | 3 | CID000237073 | |
| Drug | bromfenacoum | GPI VSNL1 DPP8 ITPKB PTP4A1 PPP3R1 SLC12A2 SORCS2 UQCRB HADHA PATJ RPL5 PLXNB1 | 3.47e-06 | 644 | 97 | 13 | ctd:C013418 |
| Drug | 1v79 | 4.13e-06 | 8 | 97 | 3 | CID000449014 | |
| Drug | tautomycin | 1.15e-05 | 118 | 97 | 6 | CID000440646 | |
| Drug | 22 G | 1.21e-05 | 11 | 97 | 3 | CID000018488 | |
| Drug | endothall | 1.64e-05 | 36 | 97 | 4 | CID000003225 | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 1.90e-05 | 193 | 97 | 7 | 997_UP | |
| Drug | Halofantrine hydrochloride [36167-63-2]; Up 200; 7.4uM; HL60; HT_HG-U133A | 2.39e-05 | 200 | 97 | 7 | 3130_UP | |
| Drug | dalcetrapib | 3.29e-05 | 15 | 97 | 3 | ctd:C411602 | |
| Drug | butylethanolamine | 4.03e-05 | 16 | 97 | 3 | CID000249006 | |
| Drug | superoxide | DOCK1 RNF19A DUOX1 NOX1 PPP3R1 PPP3R2 DNAAF10 HAAO UQCRB G6PD | 4.59e-05 | 490 | 97 | 10 | CID000520535 |
| Drug | aldosterone | 5.03e-05 | 397 | 97 | 9 | CID000005839 | |
| Drug | AC1L1BAQ | 5.37e-05 | 3 | 97 | 2 | CID000001357 | |
| Drug | 2-aminothiophenol | 5.37e-05 | 3 | 97 | 2 | ctd:C005464 | |
| Drug | AC1Q4PBB | 5.37e-05 | 3 | 97 | 2 | CID000028696 | |
| Drug | 4-(fluoromethyl)phenyl phosphate | 5.84e-05 | 18 | 97 | 3 | CID000192584 | |
| Disease | congenital nonspherocytic hemolytic anemia (implicated_via_orthology) | 1.03e-05 | 2 | 95 | 2 | DOID:2861 (implicated_via_orthology) | |
| Disease | Plasma Cell Granuloma, Pulmonary | 1.03e-05 | 2 | 95 | 2 | C0085269 | |
| Disease | acute myeloid leukemia (is_marker_for) | 1.91e-05 | 49 | 95 | 4 | DOID:9119 (is_marker_for) | |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 5.52e-05 | 64 | 95 | 4 | DOID:224 (implicated_via_orthology) | |
| Disease | Ki-1+ Anaplastic Large Cell Lymphoma | 6.13e-05 | 4 | 95 | 2 | C0206180 | |
| Disease | traumatic brain injury (biomarker_via_orthology) | 6.23e-05 | 24 | 95 | 3 | DOID:0081292 (biomarker_via_orthology) | |
| Disease | renal cell carcinoma (is_implicated_in) | 7.43e-05 | 69 | 95 | 4 | DOID:4450 (is_implicated_in) | |
| Disease | congenital nonspherocytic hemolytic anemia (is_implicated_in) | 1.02e-04 | 5 | 95 | 2 | DOID:2861 (is_implicated_in) | |
| Disease | Schizophrenia | VSNL1 ABCA13 GRIK4 NR3C1 PCDH17 TENM4 PPP3R1 SLC12A2 ULK4 DLG3 ALK | 1.28e-04 | 883 | 95 | 11 | C0036341 |
| Disease | Bipolar Disorder | 1.56e-04 | 477 | 95 | 8 | C0005586 | |
| Disease | Psychotic Disorders | 3.24e-04 | 101 | 95 | 4 | C0033975 | |
| Disease | Varicose veins | 4.09e-04 | 193 | 95 | 5 | HP_0002619 | |
| Disease | Colorectal Carcinoma | 4.41e-04 | 702 | 95 | 9 | C0009402 | |
| Disease | 3-methyl-2-oxobutyrate measurement | 4.54e-04 | 10 | 95 | 2 | EFO_0021020 | |
| Disease | diastolic blood pressure, alcohol consumption measurement | 7.12e-04 | 54 | 95 | 3 | EFO_0006336, EFO_0007878 | |
| Disease | Anemia, Hemolytic, Acquired | 7.82e-04 | 13 | 95 | 2 | C0002879 | |
| Disease | Anemia, Hemolytic | 7.82e-04 | 13 | 95 | 2 | C0002878 | |
| Disease | Anemia, Microangiopathic | 7.82e-04 | 13 | 95 | 2 | C0002889 | |
| Disease | Microangiopathic hemolytic anemia | 7.82e-04 | 13 | 95 | 2 | C0221021 | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 7.82e-04 | 13 | 95 | 2 | C3501611 | |
| Disease | skin melanoma (is_marker_for) | 7.82e-04 | 13 | 95 | 2 | DOID:8923 (is_marker_for) | |
| Disease | Neoplasm of lung | 9.10e-04 | 14 | 95 | 2 | cv:C0024121 | |
| Disease | Lung cancer | 9.10e-04 | 14 | 95 | 2 | cv:C0242379 | |
| Disease | LUNG CANCER | 9.10e-04 | 14 | 95 | 2 | 211980 | |
| Disease | Multiple congenital anomalies | 1.35e-03 | 17 | 95 | 2 | C0000772 | |
| Disease | Acute myeloid leukemia | 1.35e-03 | 17 | 95 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 1.35e-03 | 17 | 95 | 2 | 601626 | |
| Disease | pulse pressure measurement, alcohol drinking | 1.51e-03 | 70 | 95 | 3 | EFO_0004329, EFO_0005763 | |
| Disease | Lupus Erythematosus, Systemic | 1.58e-03 | 71 | 95 | 3 | C0024141 | |
| Disease | Usual Interstitial Pneumonia | 1.69e-03 | 19 | 95 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 1.69e-03 | 19 | 95 | 2 | C4721508 | |
| Disease | unipolar depression, response to bupropion, mood disorder | 1.69e-03 | 19 | 95 | 2 | EFO_0003761, EFO_0004247, EFO_0006326 | |
| Disease | cancer (implicated_via_orthology) | 1.77e-03 | 268 | 95 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | diet measurement, body mass index | 1.88e-03 | 20 | 95 | 2 | EFO_0004340, EFO_0008111 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 1.88e-03 | 20 | 95 | 2 | C4721952 | |
| Disease | Lung diseases | 2.07e-03 | 78 | 95 | 3 | C0024115 | |
| Disease | Idiopathic Pulmonary Fibrosis | 2.07e-03 | 21 | 95 | 2 | C1800706 | |
| Disease | Depression, Bipolar | 2.14e-03 | 79 | 95 | 3 | C0005587 | |
| Disease | high density lipoprotein particle size measurement | 2.25e-03 | 170 | 95 | 4 | EFO_0008592 | |
| Disease | Pseudoaphakia | 2.70e-03 | 24 | 95 | 2 | C0524524 | |
| Disease | Lens Opacities | 2.70e-03 | 24 | 95 | 2 | C1510497 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LQKLGQDEDMDVKYF | 576 | P30154 | |
| LEIMEKRYNLGDYNG | 266 | Q9H2F5 | |
| GLEMFLKAAAENQEY | 111 | Q86SG2 | |
| ALERGLQDEDGYRMK | 1601 | P0C0L5 | |
| GEEVFYQLEGDMVLR | 51 | P46952 | |
| LGMFGYDDQNTRDEL | 186 | Q86V15 | |
| LLNEGEENEMEIFGY | 11 | Q4VNC1 | |
| LEDGIIEFYLDGNAM | 1431 | Q8WXG9 | |
| EKLQTYGGLLDEMFN | 3396 | Q86UQ4 | |
| MDKDGYISNGELFQV | 101 | Q96LZ3 | |
| MDKDGYISNGELFQV | 101 | P63098 | |
| LGNYDEMKDFIGDRS | 56 | Q9UHB7 | |
| GLGKQFYEDMIDIIQ | 341 | Q9ULI1 | |
| KGNLDYEENGMLEID | 306 | O14917 | |
| GFNKLGLMRDDTIYE | 26 | P14927 | |
| EADELMKRVGFQYEG | 491 | P11413 | |
| EKYRFYEMEIQGQDG | 311 | Q9Y5H2 | |
| MLEEFAYLRTQEGGK | 631 | Q9NVR2 | |
| AFDADGDRYMILGQN | 291 | Q15124 | |
| MERYFDGNLEKLFAE | 146 | Q9Y4X5 | |
| RMYDFDGNGLISKDE | 861 | Q9NRD9 | |
| IKVYNQFMGGVDRAD | 921 | P0DP91 | |
| EQEMEELGKVGFLNY | 456 | Q9Y5S8 | |
| FLADMEALGQGKQYR | 171 | Q9BZE7 | |
| KENLFFVMEYLNGGD | 451 | Q04759 | |
| YKTQFDEGRVDGRML | 736 | Q86W92 | |
| GYDNGDIKLFDLRNM | 186 | Q96MX6 | |
| YEGERAMTKDNNLLG | 446 | P54652 | |
| LEEDGTAQKMQLGYR | 2106 | O43157 | |
| EDLFMAGQKDQLRFG | 1306 | Q9H792 | |
| DLRVRFVDNMYKGGQ | 361 | Q92917 | |
| QERGDVMDFYKTLRG | 21 | P04150 | |
| RERMFNGEKINYTEG | 81 | P06744 | |
| QGKYENKGLMIIDEE | 641 | Q9HAQ2 | |
| NGMFSEIKYDGERVQ | 501 | P49916 | |
| RYQGKMFDEESILGE | 391 | Q9P1Z3 | |
| EMKNRLYIVFEGEEG | 4041 | Q7Z6Z7 | |
| EFDEQLRMQELYGDG | 11 | O43719 | |
| ELENKALEEGNYFEM | 286 | P36888 | |
| FMEGKDFNVEYIQRG | 56 | Q9Y2K7 | |
| LGKELAEQYENEMFD | 1296 | Q14185 | |
| RQYMEGFNDELEAFK | 246 | Q16543 | |
| EYYEVIIQAKDMGGQ | 236 | Q9HBT6 | |
| IQIFEKGDFSGQMYE | 96 | P22914 | |
| GAFKYKMGQIEIDDQ | 716 | Q6V1X1 | |
| PKQGFDIYMDELEQG | 131 | P78396 | |
| MFKYEEIVLERGNSG | 126 | Q92796 | |
| FVYKGGRERTEEQME | 76 | Q7KYR7 | |
| GEDIIYMNENGEFKL | 1886 | Q99698 | |
| DEVKGEKQLGRMFYA | 276 | Q9NS66 | |
| DMYKGGKADQQEERR | 766 | Q9GZR7 | |
| GQLDYQGFEKADMVI | 431 | P40939 | |
| ETEGMDGQIYKRHLE | 366 | Q9H583 | |
| EDMRDNVIKYNDEGG | 661 | Q9UJ99 | |
| IYRMNKLGLGTDEDD | 376 | Q58FG1 | |
| MDGDKNEQERVLFLY | 4256 | Q8NDH2 | |
| QREMLEGFYEEISKG | 91 | Q9Y613 | |
| LKGNHQEMEGNDRYE | 431 | Q16099 | |
| KNRQGDENYMEFLEV | 1046 | Q9Y666 | |
| PENDDGGNYEMFTRK | 71 | Q8N3J2 | |
| ALERGLQDEDGYRMK | 1601 | P0C0L4 | |
| MGQLYEKEKDEDGFL | 91 | P60520 | |
| GLGMAYRKNADRDED | 56 | P46019 | |
| NVYIKNFGGDMDDER | 191 | P0CB38 | |
| QMENEGRGFELLLDY | 1136 | Q2M3C7 | |
| ANKRGGMYLEDLDVL | 356 | Q9Y3M8 | |
| NIEMYQKLQGSEDGL | 361 | Q8WXA3 | |
| EEMYLNEAGFNFVRK | 386 | A6NI28 | |
| MLEFYGDRDGAQEVL | 246 | Q15573 | |
| HGDVVKDGERYNQMD | 716 | P27987 | |
| KDGERYNQMDDLLAD | 721 | P27987 | |
| QYVEGMFRAFDKNGD | 56 | Q9UMX6 | |
| GNLGSQLVEYKEEMY | 531 | Q96PQ0 | |
| MIYLGKDTNGENIAE | 111 | Q7KZF4 | |
| NRFGMDKIYEGQVEV | 111 | P46777 | |
| GEIQYKMDEDGFLRQ | 2206 | Q9UKZ4 | |
| EKDDMLYILVGQQGE | 766 | Q9UM73 | |
| KEKYMEFDLNGNGDI | 51 | P55008 | |
| MKEAFQNAYLELGGL | 541 | Q13733 | |
| DERVKNGLNFMYEAP | 61 | Q86X95 | |
| MDELRGEGLEYENIK | 1286 | A4UGR9 | |
| ELQLFQGEGKMYECN | 191 | Q9HCG1 | |
| NMYDLDGDGKITRVE | 106 | P62760 | |
| MQEQEIGFISKYNEG | 1 | Q9NV58 | |
| RRLKEMGFIIYGNED | 451 | O15270 | |
| EDELLEVNGMQLYGK | 601 | Q8NI35 | |
| NEGYIMGFISKERER | 581 | P40763 | |
| DDLREGAQYLMQAAG | 861 | P55011 | |
| ELIMFIYSNGDKEDG | 66 | A0A075B6T6 | |
| LKENYQMLTLGGDAE | 1146 | Q9NTJ3 | |
| TRLGDVQYKMDEDGF | 2246 | Q6N022 | |
| VQYKMDEDGFLRQRG | 2251 | Q6N022 | |
| GEGEEYMLALKQELR | 51 | O15318 | |
| DYGGDKEIQNMDDNI | 181 | O75643 | |
| ERKYKDMNQFGEGEQ | 86 | Q00341 | |
| LMKDGDKNNDGRIDY | 136 | P63316 | |
| EGGMKYEDAVQFIRQ | 121 | Q93096 | |
| YGDMENKLFAGIRRD | 846 | O14746 | |
| MENFILYEEIGRGSK | 1 | Q96C45 | |
| SGFMEQLRTYQEGKE | 191 | Q8WTR2 |